ANI Pharmaceuticals (ANIP) said Wednesday that the US Food and Drug Administration has approved its 10 mg and 20 mg isosorbide mononitrate tablet, a generic version of the reference listed drug Monoket.
The company said it launched the product after receiving the FDA approval.
Shares of the company were up 7.1% in premarket activity Wednesday.